BACKGROUND: Lower limbs deep vein thrombosis (DVT) and pulmonary embolism (PE) are major causes of morbidity and mortality and are even higher in bariatric patients. The longer operative time and higher immobility in these patients increase the DVT risk. Although deaths after bariatric surgery have been reported, there is no consensus regarding the prophylaxis of DVT. This study's objective is to determine the incidence of lower limbs DVT in patients submitted to Roux-en-Y-gastric bypass (RYGBP) under prophylaxis by enoxaparin. METHODS: Patients with body mass index (BMI) equal to or higher than 35 kg/m(2) who submitted to RYGBP by laparotomy or laparoscopy using 40 mg/day of enoxaparin for 15 days were recruited between October 2004 and August 2005. Individuals with previous DVT and heparin allergy were excluded. Patients were tested for DVT using color Doppler ultrasound performed before surgery and on the second and fifth weeks after surgery. RESULTS: The study population included 136 patients, with 126 concluding the protocol. There were 79% (100/126) of female patients aged 19 to 65 years old, with mean of 40 years SD = 10 and BMI between 35 and 61 kg/m(2), mean of 43 kg/m(2) (SD = 5). All patients who submitted to RYGBP were divided as 55% (69/126) by laparoscopy and 45% (57/126) by laparotomy. The incidence rate of lower limbs DVT was 0.79% (1/126). CONCLUSION: The low incidence rate of DVT found in our study suggests that obesity might not be a major risk factor for venous thromboembolism in patients submitted to RYGBP.
BACKGROUND: Lower limbs deep vein thrombosis (DVT) and pulmonary embolism (PE) are major causes of morbidity and mortality and are even higher in bariatric patients. The longer operative time and higher immobility in these patients increase the DVT risk. Although deaths after bariatric surgery have been reported, there is no consensus regarding the prophylaxis of DVT. This study's objective is to determine the incidence of lower limbs DVT in patients submitted to Roux-en-Y-gastric bypass (RYGBP) under prophylaxis by enoxaparin. METHODS:Patients with body mass index (BMI) equal to or higher than 35 kg/m(2) who submitted to RYGBP by laparotomy or laparoscopy using 40 mg/day of enoxaparin for 15 days were recruited between October 2004 and August 2005. Individuals with previous DVT and heparinallergy were excluded. Patients were tested for DVT using color Doppler ultrasound performed before surgery and on the second and fifth weeks after surgery. RESULTS: The study population included 136 patients, with 126 concluding the protocol. There were 79% (100/126) of female patients aged 19 to 65 years old, with mean of 40 years SD = 10 and BMI between 35 and 61 kg/m(2), mean of 43 kg/m(2) (SD = 5). All patients who submitted to RYGBP were divided as 55% (69/126) by laparoscopy and 45% (57/126) by laparotomy. The incidence rate of lower limbs DVT was 0.79% (1/126). CONCLUSION: The low incidence rate of DVT found in our study suggests that obesity might not be a major risk factor for venous thromboembolism in patients submitted to RYGBP.
Authors: R Hull; J Hirsh; D L Sackett; D W Taylor; C Carter; A G Turpie; A Zielinsky; P Powers; M Gent Journal: Ann Intern Med Date: 1981-01 Impact factor: 25.391
Authors: A Cogo; A W Lensing; M M Koopman; F Piovella; S Siragusa; P S Wells; S Villalta; H R Büller; A G Turpie; P Prandoni Journal: BMJ Date: 1998-01-03
Authors: Kimberley Eden Steele; Michael A Schweitzer; Gregory Prokopowicz; Andrew D Shore; Lisa C B Eaton; Anne O Lidor; Martin A Makary; Jeanne Clark; Thomas H Magnuson Journal: Obes Surg Date: 2011-09 Impact factor: 4.129
Authors: Debraj Mukherjee; Anne O Lidor; Kathryn M Chu; Susan L Gearhart; Elliott R Haut; David C Chang Journal: J Gastrointest Surg Date: 2008-07-31 Impact factor: 3.452
Authors: Torgeir T Søvik; Erlend T Aasheim; Jon Kristinsson; Carl Fredrik Schou; Lien My Diep; Arild Nesbakken; Tom Mala Journal: Obes Surg Date: 2008-06-20 Impact factor: 4.129
Authors: Michel Gagner; Faith Selzer; Steve H Belle; Marc Bessler; Anita P Courcoulas; Gregory F Dakin; Dan Davis; William B Inabnet; James E Mitchell; Alfons Pomp; Gladys W Strain; Walter J Pories; Bruce M Wolfe Journal: Surg Obes Relat Dis Date: 2012-07-31 Impact factor: 4.734
Authors: Randall R De Martino; Adam W Beck; Matthew S Edwards; Matthew A Corriere; Jessica B Wallaert; David H Stone; Jack L Cronenwett; Philip P Goodney Journal: J Vasc Surg Date: 2012-07-24 Impact factor: 4.268
Authors: F Celik; F Bounif; J M Fliers; B E Kersten; F M H van Dielen; H A Cense; D P M Brandjes; B A van Wagensveld; I M C Janssen; A W J M van de Laar; V E A Gerdes Journal: Obes Surg Date: 2014-10 Impact factor: 4.129